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Abstract
Objective—Infection with Campylobacter jejuni, a bacterium carried by poultry and livestock, is
the most frequently identified antecedent to the autoimmune neurologic condition Guillain-Barré
Syndrome. We used Agricultural Health Study data to assess whether cattle farming was
associated with prevalence of neurologic symptoms.
Methods—Prevalence of self-reported symptoms in cattle farmers (n = 8878) was compared with
farmers who did not work with animals (n = 7462), using multivariate regression.
Results—Prevalence of numbness and weakness were increased for beef and dairy farmers
compared with the reference group (P < 0.0001). Of cattle farmers, 48% did not report raising
other animal species, and prevalence of numbness and weakness were also increased in this
subgroup compared with the reference group (P < 0.02).
Conclusions—Occupational exposure to cattle was associated with increased prevalence of self-
reported symptoms associated with peripheral neuropathy.
Recent research1,2 indicates that occupational exposure to farm animals at several stages of
food production may be an important source of exposure to pathogens. The bacterial
pathogen Campylobacter jejuni is particularly common in poultry but can also colonize
swine and other livestock, including cattle.3 Campylobacter spp. is the most commonly
identified bacterial cause of foodborne illness in the United States,4 and campylobacteriosis
is the leading cause of bacterial diarrhea worldwide.5 Although food-borne exposure is an
important source of Campylobacter infection, case–control studies6,7 have demonstrated
significant positive associations between exposure to farm animals, including cattle, and
Campylobacter infection. Elevated levels of anti–C. jejuni antibodies have been reported in
meat processing workers,8 poultry workers,9 and slaughterhouse workers.2
Infection with C. jejuni is the most frequently identified antecedent to Guillain-Barré
Syndrome (GBS), an autoimmune peripheral neuropathy.10–12 GBS is the leading cause of
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acute flaccid paralysis in the United States and worldwide.13 The incidence of GBS after C.
jejuni infection has been estimated to be about 1.17 per 1000 person-years, but certain
strains of C. jejuni are more strongly associated with GBS.14,15 Evidence indicates that the
mechanism for the association between C. jejuni exposure and GBS involves molecular
mimicry between C. jejuni lipo-oligosaccharides and peripheral nerve gangliosides.16–21
Peripheral neuropathy, whether motor or sensory, can have varying degrees of severity and
can be due to various causes. In GBS, the mechanism of neuropathy is autoimmune. The
two most prominent types of GBS are acute inflammatory demyelinating
polyradiculoneuropathy (AIDP), which is the most common type of GBS in North America
and Europe, and acute motor axonal neuropathy (AMAN), which is most common in China
and Mexico.12,22,23 Weakness is a symptom of both AIDP and AMAN, whereas numbness
is more associated with AIDP. In addition to GBS with its acute manifestation, there also is
a disease with a longer but heterogeneous course, called chronic inflammatory
demyelinating polyradiculoneuropathy, which also exhibits features characteristic of
autoimmune disease.24,25 AMAN is most strongly associated with C. jejuni infection, but
there is evidence that other forms of autoimmune peripheral neuropathy may be associated
with C. jejuni as well.26 Although the symptoms of GBS are often severe, with 80% to 90%
of GBS patients becoming unable to walk during their illness, we hypothesize that some
people exposed to C. jejuni may experience subclinical, or less severe, symptoms of
autoimmune peripheral neuropathy.27,28
Despite the evidence that occupational exposure to animals may be an important source of
Campylobacter infection, few studies have examined these exposures to C. jejuni as a risk
factor for development of peripheral neuropathy. In 2007, Price et al9 reported for the first
time that poultryhouse workers (n = 20) had significantly increased odds of reporting
symptoms of peripheral neuropathy compared with community referents (n = 40).
Furthermore, among men reporting poultry contact (n = 18), levels of anti–C. jejuni
antibodies were significantly higher, and immunoglobulin G antiganglioside autoantibodies
associated with autoimmune peripheral neuropathy were increased as compared with male
controls (n = 18), but with borderline statistical significance (P = 0.074).9 Davis et al29 used
the large sample size of the Agricultural Health Study (AHS) to build on the findings of
Price et al, documenting that self-reported work with swine or with both swine and poultry
was significantly associated with symptoms of peripheral neuropathy.
Campylobacter has been of particular concern in poultry, but there has also been recent
attention to the role of cattle as reservoirs of Campylobacter.30 We hypothesize that
occupational exposure to cattle may increase the risk of C. jejuni–associated autoimmune
peripheral neuropathy, including less severe, or subclinical, peripheral neuropathy. This
study examines the association between occupational exposure to dairy or beef cattle and
neurologic symptoms in AHS participants.
METHODS
This study used data from phase I of the AHS, which was originally designed to assess
associations between pesticides and other farm-related exposures and cancer and other
health outcomes.31 The AHS recruited private pesticide applicators (most of whom were
farmers) and commercial applicators applying for pesticide licenses in Iowa and North
Carolina during phase I of the AHS, which occurred between 1993 and 1997.31 Pesticide
license renewal is required every 3 years in Iowa and North Carolina; all individuals
applying for new or renewed pesticide licenses were invited to enroll in the AHS. The AHS
cohort includes more than 89,000 participants including approximately 52,400 private
pesticide applicators, 5000 commercial applicators, and 32,300 spouses of private
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applicators. The present study is a nested cross-sectional study using data collected at
enrollment (p1rel0712.01 AHS phase I data release). Further details about the AHS can be
found at http://aghealth.nci.nih.gov/ and AHS questionnaires are accessible at http://
aghealth.nci.nih.gov/questionnaires.html.
This analysis was restricted to private pesticide applicators who completed both the
enrollment questionnaire and the take-home farmer–applicator questionnaire because
information about neurologic symptoms was collected with the latter. We excluded
commercial pesticide applicators because they were less likely to work with animals.31 We
also excluded persons from this study if they were missing data about any of the nine animal
exposures or any of the five neurologic symptoms of interest. Forty-four percent of the
private pesticide applicators, a total of 22,916, completed both questionnaires, and of these,
20,599 had complete data for the exposures and outcomes of interest.
Cattle exposure was assessed on the basis of the following question from the AHS
enrollment questionnaire: “What are the major income producing crops and animals you are
currently raising on a farm? (Mark all that apply).” Marking at least one of the following
indicated animal exposure: “beef cattle,” “dairy cattle,” “hogs/swine,” “poultry,” “sheep,”
“eggs,” and “other farm animals.” An additional question from the enrollment questionnaire
was used in defining the reference group: “Which of the following activities do you perform
at least once each year? (Mark all the activities you perform).” Subjects who reported “work
in swine confinement areas” or “work in poultry areas” were considered to be exposed to
animals. The 7462 participants who did not report working with any of the earlier nine
animal categories were classified as the unexposed reference group. The 8878 participants
who reported working with either “beef cattle” or “dairy cattle” were classified as cattle
farmers. This study compared 8878 cattle farmers with 7462 farmers who reported no farm
animal exposures, with a total sample size of 16,340. Fifty-two percent of the cattle farmers
also farmed other animals. To distinguish between exposure to cattle and exposure to other
animals such as poultry that may harbor C. jejuni, the 4275 farmers who worked with cattle
but no other farm animals were also assessed as a subgroup.
Beef farmers and dairy farmers also were assessed as separate subgroups of cattle farmers
because of the possibility that occupational conditions and practices might differ between
these two groups, or that beef and dairy cattle might have different levels of C. jejuni. These
two groups are not mutually exclusive, as 426 of the participants reported working with both
beef and dairy cattle. Of the 8878 cattle farmers, 7710 farmed beef cattle only, 742 farmed
dairy cattle only, and 426 farmed both beef and dairy cattle. Thus, there were a total of 8136
beef farmers (7710 who worked with beef cattle only and 426 who worked with both beef
and dairy cattle) and a total of 1168 dairy farmers (742 who worked with dairy cattle only
and 426 who worked with both beef and dairy cattle). Each of the four groups (all cattle
farmers and the three subgroups: farmers who worked only with cattle and no other animals,
beef farmers, and dairy farmers) were individually compared with the reference group of
7462 farmers who did not report working with any farm animals.
Neurologic symptoms were assessed on the basis of the following question on the AHS
farmer–applicator questionnaire: “Approximately how often during the last 12 months have
you experienced the following?” Twenty-three symptoms were queried on the basis of
hypothesized outcomes of pesticide exposures. The original responses were “never,” “once a
year,” “once a month,” “once a week,” and “more than once a week.” The latter four
categories were collapsed into one so that analysis was based on a recoded dichotomous
variable of never experienced the symptom during the past 12 months, versus experienced
the symptom at least once in the past 12 months. Five of the symptoms were selected for
assessment: “numbness or pins-and-needles in your hands or feet,” “weakness in your arms
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or legs,” “difficulty speaking,” “blurred vision or double vision,” and “difficulty seeing at
night.” The first two symptoms were selected as consistent with peripheral neuropathy,
whereas the other three symptoms are not typical of peripheral neuropathy but may be
associated with other neurological conditions.27,28
The association between self-reported exposure to cattle and neurologic symptoms was
assessed using a similar analytic framework as used by Davis et al.29 Because the study
design was cross-sectional, prevalence ratios (PRs) were calculated to assess the prevalence
of self-reported neurologic symptoms in those exposed to cattle compared with the reference
group of those with no reported farm animal exposure. Because they directly estimate PRs,
univariate and multivariate log-binomial regression analyses were performed using SAS®
9.2 software (SAS Institute, Cary, NC) as described by Spiegelman and Hertzmark.32
On the basis of the hypothesized causal pathway between exposure to cattle and symptoms
of peripheral neuropathy, the following variables were chosen a priori for inclusion in
multivariate modeling: state (Iowa or North Carolina), gender (male or female), race (non-
Hispanic white or other), ever smoker (yes or no), ever consume alcohol in the past year
(yes or no), age (categorical), education (beyond high school vs high school or less),
frequency of consumption of each of the five types of meat or poultry products (categorical),
and use of each of the four categories of pesticides (yes or no): insecticides, herbicides,
fungicides, or fumigants. Food consumption, particularly of beef, pork, and poultry
products, was an important consideration because C. jejuni is a common food-borne
pathogen in the United States.4 Pesticide use was included because it has been associated
with neurologic symptoms in AHS participants.33 Organophosphate insecticides, in
particular, may be used to control insects in cattle farming and have been associated with
neurologic symptoms. Therefore, PRs were also assessed in an additional model that
included the covariates discussed earlier, with ever mixed or applied organophosphates (yes
or no) replacing the less specific insecticides variable.
RESULTS
Demographic and other relevant characteristics of the cattle farmers and the reference group
are presented in Table 1. All individual groups differed significantly, but in small
magnitude, from the reference group on gender, race, state, education, smoking, alcohol
consumption, and use of insecticides, fungicides, and fumigants, age, and consumption of
hamburgers, beef-steaks, chicken, and pork chops or ham steak. The majority of cattle
farmers (77.3%) were from Iowa, whereas only 49% of farmers in the reference group were
from Iowa. The mean age of cattle farmers was 3.5 years less than the mean age of the
reference group. A smaller proportion of cattle farmers had education beyond high school,
and fewer cattle farmers reported smoking, whereas more reported alcohol consumption
compared with the reference group. Cattle farmers reported more frequent consumption of
hamburgers and beef-steaks than did the reference group. A greater proportion of cattle
farmers used insecticides compared with the reference group. Less than 4% of the data for
covariates were missing for cattle farmers and the reference group.
The prevalence of self-reported neurologic symptoms is presented in Table 2. Overall, the
prevalence of the five symptoms from most to least prevalent was: numbness (27.3%),
weakness (15.3%), night blindness (12.1%), blurred vision (10.8%), and speech problems
(4.4%). PR estimates are presented in Table 3. Cattle farmers overall and all the three cattle
farmer subgroups had statistically significant positive associations for self-reported
numbness and weakness compared with the reference group in both the unadjusted and
adjusted models.
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In the adjusted model, prevalence of reported numbness (PR = 1.22; 95% confidence
interval [CI], 1.12–1.32]) and weakness (PR = 1.25; 95% CI, 1.14–1.38) was increased for
cattle farmers compared with the reference group. Significant increases in prevalence of
numbness and weakness remained for the three subgroups of cattle farmers (Table 3). The
PR for numbness in cattle farmers with no other animals compared with the reference group
was 1.15 (95% CI, 1.04–1.26). The PR for weakness in cattle farmers with no other animals
compared with the reference group was 1.16 (95% CI, 1.03–1.30). For the other three
neurologic symptoms (speech problems, blurred vision, and night blindness), PRs were not
statistically significant in the adjusted models, with the exception of an increased prevalence
of blurred vision in dairy farmers (Table 3). PR estimates and CIs remained similar when
further adjusted for organophosphate use.
DISCUSSION
The prevalence of both reported numbness and reported weakness was increased in cattle
farmers as a group and in the three subgroups of cattle farmers compared with farmers who
did not work with animals. This association is consistent with, but does not specifically
indicate, an association between occupational exposures in cattle farming and increased
prevalence of C. jejuni–associated autoimmune peripheral neuropathy. The lack of similarly
strong differences in prevalence of reported speech problems, blurred vision, and night
blindness supports this possibility, as these three symptoms are generally not associated with
autoimmune peripheral neuropathy.27
Of the AHS participants in the current study who reported raising cattle, 52% also reported
raising other animals, including poultry, swine, and sheep. Because these other farm animals
are known to carry C. jejuni, we also assessed the prevalence of symptoms in those
participants who reported working with cattle but no other farm animals. Significant
increases in prevalence of numbness and weakness remained for those farmers who farmed
only cattle, although the PRs were lower and the P values were higher. These findings
suggest that exposure to cattle in the absence of other farm-animal exposures is associated
with increased symptoms of peripheral neuropathy, and highlight a need for further research
on C. jejuni exposure via cattle.
The prevalence of symptoms of peripheral neuropathy was increased for both beef farmers
and dairy farmers. Beef farmers and dairy farmers were not directly compared with each
other, but the PRs for reported symptoms of both numbness and weakness compared with
the reference group were particularly high for dairy farmers. One study34 of 56 beef and
dairy farms in the United Kingdom demonstrated that the presence of dairy cows was
associated with increased odds of Campylobacter detection, but that finding is not
necessarily generalizable to the AHS population. The prevalence of C. jejuni in the beef and
dairy cattle raised by the farmers in the present study is unknown. Dairy farmers generally
work with cattle indoors and may have more intensive animal contact that might lead to
increased C. jejuni exposures, but this speculation would require further study to confirm.
Also, different farming practices might lead to differences in pathogen shedding or differing
job tasks might influence risks of pathogen transmission between cattle and humans. It is
also possible that beef and dairy farmers might differ in exposure to an unmeasured factor
other than C. jejuni that might contribute to symptoms of peripheral neuropathy.
The prevalence of Campylobacter in cattle may vary on the basis of herd type and herd
characteristics.35–39 Globally, Campylobacter spp. has been detected in 6% to 64% of dairy
cattle and 42% to 83% of beef cattle, based on studies in 21 different countries.5 The United
States 2002 National Animal Health Monitoring Survey, a program coordinated by the US
Department of Agriculture,40 reported Campylobacter spp. in 51% of 1435 individual cows
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sampled and nearly 98% of 96 dairy herds sampled from 21 states, with C. jejuni as the most
common type.41 This was an increase from the 1996 National Animal Health Monitoring
Survey,39 which reported detection of C. jejuni in 37.7% of dairy cattle fecal samples, with
greater than 25% of cows testing positive for C. jejuni in 80.6% of herds. Studies in various
local regions of the United States have also documented high rates of Campylobacter in
cattle.42–45
The prevalence of C. jejuni in cattle on the specific farms of the subjects of this study during
the study time period is unknown, but limited information about the prevalence of C. jejuni
in cattle in Iowa and in the eastern United States is available for periods before and after the
study time period. C. jejuni was culture-confirmed in fecal samples from 24% of 358 dairy
cattle and 19% of 252 beef cattle sampled between 2001 and 2003 at a commercial beef
packing plant in the southeastern United States that received cattle from several areas in the
eastern United States.43 The prevalence of thermophilic Campylobacter detected in the bile
of 477 cull dairy cows at a central Iowa packing plant in the early 1980s was 15.5%, and
91% of these Campylobacter isolates were C. jejuni.45
Inferences as to a potential role of C. jejuni exposure in the observed symptoms are limited
by a lack of specific information about C. jejuni exposure for the individuals or groups in
this analysis. Exposure to other unmeasured risk factors, including other pathogens, may
have been involved as other pathogens have been associated with GBS.11 Moreover, the
observed increase in prevalence of symptoms of numbness and weakness may or may not be
associated with autoimmune pathophysiology. These symptoms are not specific to
autoimmune peripheral neuropathy and may be attributed to other causes that do not involve
autoimmune mechanisms, such as physical trauma. We conducted this research on the basis
of the hypothesis that cattle farmers would have an increased prevalence of symptoms due to
increased C. jejuni exposure, and attempted to adjust for other potential contributors to
neurologic symptoms, including pesticide exposure. The results were reassuringly similar
when we adjusted for organophosphate use, but the possibility remains that cattle farmers
may differ from farmers who do not work with animals on more specific pesticide
exposures, and that such differences might account for some of the observed increase in
prevalence of numbness and weakness in cattle farmers. It is also possible that cattle farmers
may be more susceptible to repetitive motion injuries or to cold or to some other
unmeasured precursor to symptoms of numbness and weakness. Thus, the findings of this
study indicate that cattle farmers in the AHS have an increased prevalence of symptoms of
numbness and weakness, but do not confirm the cause of these symptoms. Specific
measurement of anti–C. jejuni antibodies and antiganglioside autoantibodies would be
necessary to rule out other possible causes. The symptoms were self-reported and the data
were obtained using a questionnaire that was not originally designed to assess risks of
autoimmune peripheral neuropathy. Further information, such as nerve conduction velocity
tests and electromyography, would be needed for diagnostic purposes. Because such
diagnostic information was not available for this study, it is not clear what kind of
neuropathy process, if any, may have contributed to the observed symptoms. Longitudinal
assessment of serum antiganglioside autoantibodies associated with GBS could provide
further information about whether the observed symptoms may be associated with
subclinical autoimmune peripheral neuropathy. Thus, future research using biomarkers,
particularly anti–C. jejuni antibodies and antiganglioside autoantibodies, could more
specifically assess whether the observed increase in symptoms of numbness and weakness in
cattle farmers is due to C. jejuni–associated autoimmune pathophysiology.
Another limitation of the study is that PRs might be underestimated due to the healthy
worker effect. Farmers who experienced significant adverse symptoms while working with
cattle might have chosen to stop working with cattle before the initiation of the study.
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Because participants were only asked about current animal exposures, such participants who
might have previously switched from animal farming to crop farming would be included in
the reference group, which would decrease the observed association.
Despite the high prevalence of Campylobacter in cattle, there is a dearth of research on
peripheral neuropathy in cattle farmers, and this study provides important information and
rationale for further research to address this issue. The nesting of this study within the AHS
provides several strengths including a large sample size, a relevant reference group, the
ability to adjust for important potential confounders, and the ability to assess the prevalence
of self-reported symptoms of peripheral neuropathy as well as neurologic symptoms that are
not typical of peripheral neuropathy.
The findings of this study indicate that occupational exposure to cattle is associated with
symptoms of peripheral neuropathy. Further clarification of this potentially important health
risk would be beneficial to informing the development and implementation of policies to
protect the health of farmworkers and rural communities.
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